Clinical Trials Browser

Phase 1 × Recurrence × lorvotuzumab mertansine × Clear all

NCT00991562 2014-11-21

IMGN901 in Combination With Lenalidomide and Dexamethasone

Phase 1 Completed

Multiple Myeloma, Recurrence